Orion Pharma Limited (DSE:ORIONPHARM)

Orion Pharma Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	50.96	72.1	147.73	130.11	106.13	414.99
Short-Term Investments	55.16	54.18	45.82	38.68	31.83	23.62
Cash & Short-Term Investments	106.12	126.28	193.55	168.79	137.97	438.61
Cash Growth	-32.95%	-34.75%	14.67%	22.34%	-68.54%	-58.38%
Accounts Receivable	4,368	4,390	4,210	5,584	6,796	3,943
Other Receivables	10,589	10,656	10,267	9,811	8,109	8,458
Receivables	14,957	15,046	14,477	15,395	14,905	12,401
Inventory	1,549	1,505	1,699	1,614	1,660	1,411
Prepaid Expenses	3.6	-	0.11	1.1	26.19	43.84
Other Current Assets	863.63	859.62	1,045	1,897	2,026	1,928
Total Current Assets	17,480	17,537	17,415	19,076	18,755	16,223
Property, Plant & Equipment	31,401	30,937	28,951	26,424	23,009	19,856
Long-Term Investments	8,276	7,322	8,067	7,440	6,343	6,254
Total Assets	57,157	55,796	54,433	52,940	48,107	42,333
Accounts Payable	5,570	6,710	6,136	6,259	7,301	4,231
Accrued Expenses	273.8	278.28	298.44	270.03	265.44	232.48
Short-Term Debt	458.08	493.7	556.18	547.82	563.9	564.32
Current Portion of Long-Term Debt	-	-	67.35	490.5	387.47	274.33
Current Portion of Leases	13.67	14.93	13.94	23.91	31.66	36.42
Current Income Taxes Payable	325.93	321.16	304.49	435.26	398.62	262.75
Other Current Liabilities	1,771	645.99	390.05	1,444	488.23	406.06
Total Current Liabilities	8,412	8,464	7,766	9,470	9,437	6,008
Long-Term Debt	25,666	25,137	23,111	20,808	17,601	15,930
Long-Term Leases	30.73	31.69	13.71	26.35	35.27	39.9
Long-Term Deferred Tax Liabilities	418.82	402.12	315.43	157.7	122.25	138.28
Other Long-Term Liabilities	143.41	143.41	143.41	143.41	143.41	143.41
Total Liabilities	34,671	34,178	31,350	30,606	27,338	22,259
Common Stock	2,340	2,340	2,340	2,340	2,340	2,340
Additional Paid-In Capital	8,017	8,017	8,017	8,017	8,017	8,017
Retained Earnings	6,788	6,857	7,499	7,400	6,978	6,401
Comprehensive Income & Other	3,883	2,932	3,683	3,067	1,978	1,905
Total Common Equity	21,028	20,146	21,540	20,824	19,313	18,663
Minority Interest	1,457	1,472	1,543	1,510	1,456	1,412
Shareholders' Equity	22,485	21,618	23,083	22,334	20,769	20,074
Total Liabilities & Equity	57,157	55,796	54,433	52,940	48,107	42,333
Total Debt	26,169	25,677	23,762	21,897	18,619	16,844
Net Cash (Debt)	-26,049	-25,539	-23,552	-21,700	-18,446	-16,377
Net Cash Per Share	-111.32	-109.14	-100.65	-92.74	-78.83	-69.99
Filing Date Shares Outstanding	234	234	234	234	234	234
Total Common Shares Outstanding	234	234	234	234	234	234
Working Capital	9,067	9,073	9,648	9,606	9,318	10,216
Book Value Per Share	89.86	86.09	92.05	88.99	82.53	79.76
Tangible Book Value	21,028	20,146	21,540	20,824	19,313	18,663
Tangible Book Value Per Share	89.86	86.09	92.05	88.99	82.53	79.76

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.